Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Musaad AlHamzah

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Vascular Surgery|April 15, 2024
Predicting the need for subclavian artery revascularization in thoracic endovascular aortic repair: A systematic review and meta-analysisTariq Alanezi, Abdulmajeed Altoijry, Sultan AlSheikh, et al.
Healthcare (Basel, Switzerland)|September 27, 2025
Etiologies and Trends in Extremity Amputations: A Ten-Year Single-Center ExperienceAbdulrahman Alaseem, Mishari Alanezi, Mohammed N Alhuqbani, et al.
Research and Practice in Thrombosis and Haemostasis|January 3, 2022
Randomized trials of therapeutic heparin for COVID-19: A meta-analysisMichelle Sholzberg, Bruno R da Costa, Grace H Tang, et al.
Trials|March 11, 2021
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trialMichelle Sholzberg, Grace H Tang, Elnara Negri, et al.
BMJ (Clinical Research Ed.)|October 15, 2021
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trialMichelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Heparin for Moderately Ill Patients with Covid-19Michelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Vascular Surgery|April 15, 2024
Predicting the need for subclavian artery revascularization in thoracic endovascular aortic repair: A systematic review and meta-analysisTariq Alanezi, Abdulmajeed Altoijry, Sultan AlSheikh, et al.
Healthcare (Basel, Switzerland)|September 27, 2025
Etiologies and Trends in Extremity Amputations: A Ten-Year Single-Center ExperienceAbdulrahman Alaseem, Mishari Alanezi, Mohammed N Alhuqbani, et al.
Research and Practice in Thrombosis and Haemostasis|January 3, 2022
Randomized trials of therapeutic heparin for COVID-19: A meta-analysisMichelle Sholzberg, Bruno R da Costa, Grace H Tang, et al.
Trials|March 11, 2021
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trialMichelle Sholzberg, Grace H Tang, Elnara Negri, et al.
BMJ (Clinical Research Ed.)|October 15, 2021
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trialMichelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Heparin for Moderately Ill Patients with Covid-19Michelle Sholzberg, Grace H Tang, Hassan Rahhal, et al.
Pageof 2